Perez Ruixo JJ - Search Results

1

Romiplostim dose-response in patients with myelodysplastic syndromes.

Perez Ruixo JJ, Doshi S, Wang YM, Mould DR. Perez Ruixo JJ, et al. Br J Clin Pharmacol. 2013 Jun;75(6):1445-54. doi: 10.1111/bcp.12041. Br J Clin Pharmacol. 2013. PMID: 23171070 Free PMC article.

2

Mechanistic modeling projections of antibody persistence after homologous booster regimens of COVID-19 vaccine Ad26.COV2.S in humans.

Dari A, Jacqmin P, Iwaki Y, Neyens M, Le Gars M, Sadoff J, Hardt K, Ruiz-Guiñazú J, Pérez-Ruixo JJ. Dari A, et al. Among authors: perez ruixo jj. CPT Pharmacometrics Syst Pharmacol. 2023 Oct;12(10):1485-1498. doi: 10.1002/psp4.13025. Epub 2023 Sep 15. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37715342 Free PMC article.

3

Model-based meta-analysis to quantify the effects of short interfering RNA therapeutics on hepatitis B surface antigen turnover in hepatitis B-infected mice.

Sandra L, T'jollyn H, Vermeulen A, Ackaert O, Perez-Ruixo JJ. Sandra L, et al. Among authors: perez ruixo jj. CPT Pharmacometrics Syst Pharmacol. 2024 May;13(5):729-742. doi: 10.1002/psp4.13129. Epub 2024 Mar 24. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38522000 Free PMC article. Review.

4

Exposure-toxicity relationships for tipifarnib in cancer patients.

Perez-Ruixo JJ, Chen W, Zhang S, Hayes S, Chow A. Perez-Ruixo JJ, et al. Br J Clin Pharmacol. 2007 Aug;64(2):219-32. doi: 10.1111/j.1365-2125.2007.02883.x. Epub 2007 Mar 22. Br J Clin Pharmacol. 2007. PMID: 17378913 Free PMC article. Clinical Trial.

5

Pharmacokinetic and pharmacodynamic modeling of pegylated thrombopoietin mimetic peptide (PEG-TPOm) after single intravenous dose administration in healthy subjects.

Samtani MN, Perez-Ruixo JJ, Brown KH, Cerneus D, Molloy CJ. Samtani MN, et al. Among authors: perez ruixo jj. J Clin Pharmacol. 2009 Mar;49(3):336-50. doi: 10.1177/0091270008329559. J Clin Pharmacol. 2009. PMID: 19246731 Clinical Trial.

6

Exposure-response modeling of darbepoetin alfa in anemic patients with chronic kidney disease not receiving dialysis.

Doshi S, Chow A, Pérez Ruixo JJ. Doshi S, et al. Among authors: perez ruixo jj. J Clin Pharmacol. 2010 Sep;50(9 Suppl):75S-90S. doi: 10.1177/0091270010377201. J Clin Pharmacol. 2010. PMID: 20881221

7

Pharmacodynamics-mediated drug disposition (PDMDD) and precursor pool lifespan model for single dose of romiplostim in healthy subjects.

Wang YM, Krzyzanski W, Doshi S, Xiao JJ, Pérez-Ruixo JJ, Chow AT. Wang YM, et al. Among authors: perez ruixo jj. AAPS J. 2010 Dec;12(4):729-40. doi: 10.1208/s12248-010-9234-9. Epub 2010 Oct 21. AAPS J. 2010. PMID: 20963535 Free PMC article.

8

Population pharmacokinetic meta-analysis of denosumab in healthy subjects and postmenopausal women with osteopenia or osteoporosis.

Sutjandra L, Rodriguez RD, Doshi S, Ma M, Peterson MC, Jang GR, Chow AT, Pérez-Ruixo JJ. Sutjandra L, et al. Among authors: perez ruixo jj. Clin Pharmacokinet. 2011 Dec 1;50(12):793-807. doi: 10.2165/11594240-000000000-00000. Clin Pharmacokinet. 2011. PMID: 22087866

9

Romiplostim dose response in patients with immune thrombocytopenia.

Perez-Ruixo JJ, Green B, Doshi S, Wang YM, Mould DR. Perez-Ruixo JJ, et al. J Clin Pharmacol. 2012 Oct;52(10):1540-51. doi: 10.1177/0091270011420843. Epub 2011 Dec 13. J Clin Pharmacol. 2012. PMID: 22167563 Clinical Trial.

10

Denosumab dose selection for patients with bone metastases from solid tumors.

Doshi S, Sutjandra L, Zheng J, Sohn W, Peterson M, Jang G, Chow AT, Pérez-Ruixo JJ. Doshi S, et al. Among authors: perez ruixo jj. Clin Cancer Res. 2012 May 1;18(9):2648-57. doi: 10.1158/1078-0432.CCR-11-2944. Epub 2012 Mar 6. Clin Cancer Res. 2012. PMID: 22394983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters